The short answer
Opdivo (Nivolumab) is a type of immunotherapy called an immune checkpoint inhibitor. It blocks the PD-1 protein that some cancers use to switch off immune cells, helping the immune system recognize and attack the cancer. It is used to help treat melanoma, lung cancer, kidney cancer, and other cancers, and is usually given as an IV infusion, sometimes with another immunotherapy. Like all cancer medicines it can cause side effects; this page explains the common ones and the warning signs to report. It is educational only and not a substitute for your care team's advice.
Opdivo is the brand name; its generic name is nivolumab.
It is a type of immunotherapy called an immune checkpoint inhibitor — it blocks the PD-1 protein that some cancers use to switch off immune cells, helping the immune system recognize and attack the cancer.
It is used to help treat melanoma, lung cancer, kidney cancer, and several other cancers.
It is usually given as an IV infusion, sometimes with another immunotherapy.
Choose how you want to read this
The whole article, with every detail and caution.
This page is for people offered nivolumab (Opdivo), and their families. It covers how it works, where it is approved, the two ways it is given, immune side effects, and when to get help.
Taking a brake off your own immune system
Nivolumab does not attack cancer cells. It works on your immune system instead.
T cells, a type of immune cell, carry a switch called PD-1. When PD-1 is pressed, the T cell stands down. This is normal, and it stops the immune system attacking healthy tissue. Many tumors press that switch on purpose, so the T cells around them never act.
Nivolumab covers PD-1 so the tumor cannot press it. The T cells stay switched on. Opdivo is the brand name. Nivolumab is the generic name.
Where it is approved to be used
Nivolumab has one of the longest approval lists in cancer care. It covers melanoma, non-small cell lung cancer, mesothelioma, kidney cancer, classical Hodgkin lymphoma, head and neck cancer, bladder and urinary tract cancer, bowel cancer with MSI-high or dMMR results, liver cancer, and cancers of the esophagus and stomach.
The details inside each of those matter. Some approvals are for advanced disease, some are given after surgery, and some are only for tumors with a certain PD-L1 result. Some are for nivolumab alone and some only in a pair with ipilimumab, or with chemotherapy. Ask your team which line on that list is yours.
Drip or injection: two ways it is now given
The original form, Opdivo, is a drip into a vein. It runs over about half an hour, every two, three or four weeks.
There is now also a version given as an injection under the skin. It is called Opdivo Qvantig, and it mixes nivolumab with an enzyme that helps it spread through the tissue. The label says a healthcare professional gives it over 3 to 5 minutes, rather than 30. It is not approved with ipilimumab, so it is not a swap you can simply request.
Immune side effects can reach any organ
The label lists tiredness, rash, itching, diarrhea, nausea and muscle or bone pain as the most common effects.
The effects to know about are different. Because the drug lifts a brake on the immune system, immune cells can turn on healthy tissue. The label is blunt about this: it can happen in any organ or tissue. The label names the lungs, bowel, liver, hormone glands, kidneys and skin.
Two points get missed. These reactions can start at any time in treatment. They can also start weeks or months after your last dose.
Signs that need help now
Call 911 if you have chest pain, if you struggle to breathe at rest, or if a rash is blistering or peeling off in sheets. Do not drive yourself.
The label tells you to contact your healthcare provider immediately, not at the next appointment, for:
- A new or worsening cough, chest pain, or shortness of breath
- Diarrhea, or severe belly pain
- Yellow skin or eyes, dark urine, belly pain, or unusual bleeding or bruising
- Signs of a hormone gland problem, which can include unusual tiredness or weakness, feeling very cold or hot, headaches, vision changes, or extra thirst and urinating
- Any rash, itching or blistering
- Changes in how much you urinate, or muscle weakness
Do not wait to see if these settle. Serious reactions are treated with steroids, so do not delay.
The blood tests along the way
Before you start, and then regularly, your team checks liver enzymes, kidney function and thyroid hormones. These pick up problems before you feel them. Thyroid problems can be treated with hormone medicine.
If you have had a stem cell transplant from a donor, or may have one later, tell your team. The label flags serious complications when this drug and that transplant are combined.
Sources
Common questions
What is Opdivo?
Opdivo (Nivolumab) is a type of immunotherapy called an immune checkpoint inhibitor. It blocks the PD-1 protein that some cancers use to switch off immune cells, helping the immune system recognize and attack the cancer. It is used to help treat melanoma, lung cancer, kidney cancer, and several other cancers.
How is Opdivo given?
It is usually given as an IV infusion, sometimes with another immunotherapy. It is given as an intravenous (IV) infusion — a slow drip into a vein — at a clinic or hospital, usually repeated on a schedule of cycles with rest periods in between. The exact schedule is set by your care team.
What are the common side effects of Opdivo?
Commonly reported side effects include tiredness, rash or itching, diarrhea, nausea, and aches. Not everyone gets them, and many can be managed. Tell your care team about anything new or worsening.
Does Opdivo cure cancer?
That depends on the person, the cancer type, and its stage. For some people a medicine like this can control cancer for a long time or be part of a curative plan; for others the goal is to slow the cancer or ease symptoms. Your care team can explain the goal in your situation.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Talk with a trained specialist or navigator
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Fever of 100.4°F (38°C) or higher during chemo, severe pain, or trouble breathing: call your cancer care team right away, day or night. Call 911 for an emergency.
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Sources last checked: 2026-08-13 what this meansLast updated: 2026-10-02Next planned review: 2027-01-14
Review details and limits
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Editorial review complete. This page completed Cancer Explained's editorial checks (sources, safety, plain language, duplication). It has not been reviewed by a physician or other healthcare professional.
General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Words to know
Tap any term to see what it means.
Knowledge check
0 of 2 answered
This self-assessment checks understanding of educational content only. It is not medical advice.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Editorial review complete — This page completed Cancer Explained's editorial checks (sources, safety, plain language, duplication). It has not been reviewed by a physician or other healthcare professional.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.